TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis, including profits, estimated losses, and the documents you will need for claim filing and settlement recovery.

Settlement Filing Deadlines

Companysort icon Amount Files Deadline
Audioeye - OTC: AEYE $1,525,000 notice proof 04/24/2017
Barrett Business... - NASDAQ: BBSI $12,000,000 notice proof 03/21/2017
BP - NYSE: BP $175,000,000 notice proof 04/01/2017
China Finance On... - NASDAQ: JRJC $3,000,000 notice proof 03/03/2017
China North East... -
OTCBB: CNEP
OTC: CNEP
$925,000 notice proof 03/06/2017
Citizens Busines... - NASDAQ: CVBF $6,200,000 notice proof 04/18/2017
EZCORP - NASDAQ: EZPW $5,900,000 notice proof 05/19/2017
Fifth Street Ass... - NASDAQ: FSAM $9,250,000 notice proof 03/27/2017
KaloBios Pharmac... - NASDAQ: KBIO $1,500,000 notice proof 04/06/2017
King Digital Ent... - NYSE: KING $18,500,000 notice proof 05/23/2017
Molycorp - NYSE: MCP $1,250,000 notice proof 05/18/2017
Quiksilver - NYSE: ZQK $1,500,000 notice proof 05/10/2017
Revance Therapeu... - NASDAQ: RVNC $6,400,000 notice proof 06/05/2017
Sientra - NASDAQ: SIEN $10,900,000 notice proof 05/08/2017
Tile Shop Holdin... - NASDAQ: TTS $9,500,000 notice proof 05/03/2017
Universal Travel... - NYSE: UTA $4,075,000 notice proof 03/18/2017

Company or Ticker Search

Latest Aquisition

CoLucid Pharmaceuticals Deal Case 02/22/2017

February 22, 2017 (Shareholders Foundation) - An investor, who currently holds shares of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD), filed a lawsuit in effort to halt the proposed takeover of CoLucid Pharmaceuticals Inc by Eli Lilly and Company for $46.50 per share is unfair to NASDAQ:CLCD stockholders.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CLCD stockholders by agreeing to sell CoLucid...

here